1. 1605PDHealth-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line. (23rd October 2018) Authors: Grünwald, V; Schuler, M; Schöffski, P; Kopp, H-G; Bauer, S; Kasper, B; Lindner, L H; Chemnitz, J M; Crysandt, M; Stein, A; Steffen, B; Richter, S; Kneba, M; Egerer, G; Zimmermann, S; Karch, A; Kunitz, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1715PSoft tissue sarcomas express a distinct mRNA immune profile. (1st October 2019) Authors: Grünwald, V; Laenger, F; Kunitz, A; Schuler, M; Schoeffski, P; Kopp, H-G; Bauer, S; Kasper, B; Lindner, L; Chemnitz, J M; Crysandt, M; Stein, A; Steffen, B; Kneba, M; Egerer, G; Zimmermann, S; Ivanyi, P; Karch, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗